Steward Partners Investment Advisory, LLC Prothena Corp Public LTD CO Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$42.11 - $73.26 $1,052 - $1,831	-25 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$7.54 - $15.77 $3,770 - $7,885	-500 Reduced 95.24%	25 $0
Q3 2019 Oct 30, 2019	BUY	$6.89 - $10.45 $172 - $261	25 Added 5.0%	525 $4,000
Q2 2019 Jul 25, 2019	BUY	$8.85 - $12.49 $4,425 - $6,245	500 New	500 $5,000
Q4 2018 Jan 15, 2019	SELL	$8.73 - $13.74 $4,365 - $6,870	-500 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$12.7 - $15.79 $6,350 - $7,895	500 New	500 $7,000

185

42.8M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $668M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.